The Microbial Pathway That Shuts Down Diabetes Inflammation

Translate to Spanish or other 102 languages!

Bacteria in the gut may produce beneficial metabolites when breaking down certain foods. Image for illustration purposes
Bacteria in the gut may produce beneficial metabolites when breaking down certain foods. Image for illustration purposes
- Advertisement -

Medical News Today

Bacteria in the gut may produce beneficial metabolites when breaking down certain foods

Globally, diabetes affects roughly 529 million individuals. In the United States, estimates suggest that more than 30 million people are living with type 2 diabetes.

- Advertisement -

Type 2 diabetes can develop when the body no longer responds correctly to the hormone insulin. This is known as insulin resistance. Inflammation can cause insulin resistance by triggering the immune system to release signals that block insulin’s action.

This resistance can increase blood sugar and insulin levels, which further fuels inflammation, creating a self-perpetuating state that drives metabolic disease such as type 2 diabetes.

Follow the link below to Medical News Today to read the full stor/y:

https://www.medicalnewstoday.com/articles/diabetes-fighting-gut-molecule-may-help-lower-insulin-resistance?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-12-17&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

$281 Million Unlocked to Bridge the Gap in Rural Medical Access

AUSTIN - Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will receive $281 million in federal funding for the second year of Rural Texas Strong, a five-year initiative to improve rural healthcare throughout the state.

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.
- Advertisement -